0:00
/

SynBio from Lab to Market: VC Insights for Deep Tech Startups | Deep Tech Catalyst

Chloë Payne, principal at Ponderosa Ventures, on how SynBio founders navigate regulation, pricing, capital efficiency, market validation, and the milestones investors need to see.

Synthetic biology (SynBio) isn't just about science; it's also about how these scientific innovations are turned into products and solutions that meet market needs. Its applications are extensive, ranging from enhancing food flavors to revolutionizing carbon sequestration practices through innovative uses of natural systems and genetic engineering.

However, the path from lab to market can be challenging for founders, from building a scalable plan to navigating regulatory matters.

We had the pleasure of hosting Chloë Payne, Principal at Ponderosa Ventures, to cover the basics of the SynBio industry and help aspiring STEM founders take their first steps into entrepreneurship.

Welcome to the 44th episode of Deep Tech Catalyst, the channel by The Scenarionist where science meets venture!

Key Themes Covered:

  • 🧬 Understanding Synthetic Biology (SynBio) and Its Applications

  • 🗺️ Navigating Regulatory Scenarios in the Food Industry

  • 🎯 Pricing Strategy Basics for SynBio Innovations

  • 📈 Capital Efficiency and Scalability in Synthetic Biology Innovation

  • 🎯 Green Lights and Red Flags for VCs in Early-Stage SynBio


BEYOND THE CONVERSATION — STRATEGIC INSIGHTS FROM THE EPISODE

Keep reading. It’s free.

Join The Scenarionist community to unlock the full episode notes and key takeaways. Subscribe for free to continue reading.


Disclaimer
All materials published by The Scenarionist are provided solely for informational and educational purposes. They do not constitute financial, legal, or tax advice, nor do they constitute a recommendation, offer, or solicitation to buy or sell securities, crypto assets, or any other assets. The Scenarionist strives to provide accurate information but does not guarantee that its materials are complete, current, or free from errors, and assumes no liability for any reliance placed on them. Any external partnership or sponsored content will be clearly identified as “Brought to you by.” Unless otherwise disclosed, the companies and technologies mentioned do not sponsor The Scenarionist and are not included in its investment holdings. Artificial intelligence tools may be used for operational support and content refinement.

Ready for more?